SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Profit Before Tax | ₹1,553 Cr | ₹-343 Cr | ₹-387 Cr | ₹-223 Cr |
| Adjustment | ₹41 Cr | ₹21 Cr | ₹-11 Cr | ₹6.99 Cr |
| Changes In working Capital | ₹-1,865 Cr | ₹-47 Cr | ₹-27 Cr | ₹141 Cr |
| Cash Flow after changes in Working Capital | ₹-270 Cr | ₹-369 Cr | ₹-425 Cr | ₹-74 Cr |
| Cash Flow from Operating Activities | ₹-239 Cr | ₹-360 Cr | ₹-429 Cr | ₹-69 Cr |
| Cash Flow from Investing Activities | ₹-23 Cr | ₹158 Cr | ₹392 Cr | ₹-548 Cr |
| Cash Flow from Financing Activities | ₹261 Cr | ₹199 Cr | ₹42 Cr | ₹617 Cr |
| Net Cash Inflow / Outflow | ₹-0.89 Cr | ₹-3.38 Cr | ₹4.74 Cr | ₹-0.64 Cr |
| Opening Cash & Cash Equivalents | ₹1.96 Cr | ₹5.33 Cr | ₹0.58 Cr | ₹1.22 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹0.08 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
| Closing Cash & Cash Equivalent | ₹1.16 Cr | ₹1.96 Cr | ₹5.33 Cr | ₹0.58 Cr |
Compare Cashflow Statement of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,402.4 Cr | -3.9% | -16.1% | 38.3% | Stock Analytics | |
| PRIME FOCUS | ₹20,707.6 Cr | -5.4% | -8.2% | 73.3% | Stock Analytics | |
| SAGILITY | ₹19,848.8 Cr | -1.4% | 1.6% | -6.5% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,278.0 Cr | -1% | -3.4% | -38.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,356.8 Cr | 2.4% | 2.6% | 0.1% | Stock Analytics | |
| INDEGENE | ₹13,544.7 Cr | -0.9% | 10.3% | -2.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -3.9% |
-16.1% |
38.3% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses